| Chain characteristics | Human IG chain types | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heavy chain (H) | Light chain (L) | ||||||||||||||
| μ | δ | γ1 | γ2 | γ3 | γ4 | α1 | α2 | ε | κ | λ | |||||
| Molecular weight (kDa) | 70 | 60 | 50 | 50 | 53-57 | 50 | 55 | 55 | 70 | 25 | 25 | ||||
| Number of variable (V) domains | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||
| Number of constant (C) domains | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 1 | 1 | ||||
| Length (in number of amino acids) |
Constant region | CH1 (for H) or CL (for L) | 104 | 101 | 97 | 97 | 98 | 97 | 104 | 102 | 103 | 107 | 104 or 106 | ||
| CH2 | 112 | 108 | 109 | 108 | 110 | 109 | 101 | 101 | 107 | - | - | ||||
| CH3 | 112 | 108 | 106 | 106 | 105 | 106 | 112 | 111 | 108 | - | - | ||||
| CH4 | 111 | - | - | - | - | - | - | - | 110 | - | - | ||||
| Hinge region | 0 | 58 | 15 | 12 | 32, 47 or 62 |
12 | 19 | 6 | 0 | - | - | ||||
| Membrane IG | Connecting region (CO) | 13 | 27 | 18 | 18 | 18 | 18 | 32 | 32 | 15 | - | - | |||
| Transmembrane region (TM) | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | - | - | ||||
| Cytoplamic region (CY) | 1 | 1 | 26 | 26 | 26 | 26 | 12 | 12 | 26 | - | - | ||||
| Secreted IG | CHS (1) | 20 | 9 | 2 | 2 | 2 | 2 | 20 | 20 | 2 | - | - | |||
| N-glycosylation sites (2) | 5 | 3 | 1 | 1 | 2 | 1 | 2 | 4 | 7 | 0 | 0 | ||||
| O-glycosylation sites (3) | - | 7 | - | - | - | - | 8 | - | - | - | 0 | ||||
| Allotypes | none | none | G1m | G2m | G3m | G4m | none | A2m | Em | Km | none | ||||
Notes:
(1) CHS corresponds to the tailpiece of secreted IG (see Chapter 3 of the Immuglobulin FactsBook).
(2) Only indicated for the C-REGION. N-glycosylation sites may be found in some V domains.
(3) O-glycosylation sites are located in the hinge regions of the IG delta and alpha1 chains.
See also: